Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Opioid Overdose Antidote Enantiomer Could Prevent Pre-Term Birth

XTALKS VITALS NEWS

Prenatal Health

The research – which was published in the Nature journal, Scientific Reports – provides a more in-depth understanding of the inflammatory response that can lead to premature labour.

Share this!

November 21, 2016 | by Sarah Hand, M.Sc.

University of Adelaide researchers have shown that a similar drug to that which is used to treat opioid overdoses, (+)-naloxone, could show promise in the prevention of pre-term birth. The research – which was published in the Nature journal, Scientific Reports – provides a more in-depth understanding of the inflammatory response that can lead to premature labour.

(+)-Naloxone is a small molecule TLR4 antagonist, and a version of the drug which has no affinity for opioid receptors. This drug has a different mode of action compared to its counterpart, (−)-naloxone, because they are mirror images – or, enantiomers – of each other.

The researchers chose (+)-naloxone as a potential candidate for the study, due to its ability to inhibit pro-inflammatory pathways. When the drug was administered to pregnant mice, pre-term births were completely prevented, leading to a lower infant mortality rate and more consistent birth weights.

Pre-term birth is defined as that which occurs before 37 weeks of gestation. As the leading cause of death in children younger than five, pre-term birth results in 1.1 million annual deaths.



“New interventions are urgently needed to tackle the underlying causes of pre-term birth, prevent infant deaths and reduce the impact of a wide range of developmental impairments which can have lifelong health consequences,” said lead author and Director of the Robinson Research Institute, Professor Sarah Robertson. Twelve percent of all worldwide births are pre-term.

Bacterial infection has been identified as the cause of approximately half of all cases of pre-term birth. Other factors which increase the risk of premature labour include physical injury and stress, carrying multiple children and environmental pollutants. If a pregnant women is exposed to any of these risk factors, an inflammatory cascade can be triggered which activates the maternal immune system leading to pre-term birth.

An immune receptor known as TLR4 is responsible for initiating the inflammatory cascade in the case of physical injury or stress. While the receptor is necessary for a fully-functional immune system, its activities during pregnancy could be dangerous for both mother and baby.

“TLR4 is a trigger of spontaneous pre-term birth,” said Robertson. “For this reason, we wanted to test a drug known for its ability to block the actions of TLR4, to see if that would also prevent pre-term birth.

“We found that by treating pregnant mice with (+)-naloxone, it provided complete protection against pre-term birth triggered by bacteria. It also protected against stillbirth and infant death shortly after birth, and led to a correction in birth weight among infants that would otherwise be born at very low birth weight.”

While drugs used to prevent pre-term birth are currently available, Robertson points out that these are often used too late in the birth process. Of course, further preclinical studies of (+)-naloxone will need to be completed before the drug can be tested in human clinical trials.


Keywords: Opioid, Inflammation, Prenatal Health


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
German Merck Launches Spinoff Immuno-Oncology Company

June 22, 2017 - Merck KGaA has announced the launch of iOnctura SA, a new immuno-oncology company built around two assets from the Healthcare R&D portfolio of the pharmaceutical company.

Featured In: Biotech News


Ikea Promotes Food Products by Offering Fill-in-the-Blanks Recipe Sheets

June 21, 2017 - In an effort to promote the company’s food business, Ikea recently launched a set of recipes printed on parchment paper that encourage consumers to “fill-in-the-blanks” with ingredients, fold the paper and cook the bag in the oven.

Featured In: Food News


Nanomaterial Promotes Bone Growth after Spinal Fusion Surgery

June 21, 2017 - Researchers at Northwestern University have developed a bioactive nanomaterial capable of effectively stimulating bone regeneration after spinal fusion surgery.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Drug Development During the Last Week

REGISTER FOR THESE WEBINARS

Serialized? Yes. But are Products Still Being Diverted?


Quantitative Protein Profiling in FFPE to Characterize Toxicities Associated with Immune Checkpoint Inhibitors


Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model


Imaging-based Subtypes of Pancreatic Cancer


Copyright © 2016-2017 Honeycomb Worldwide Inc.